Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Stem Cell Culture01:17

Stem Cell Culture

5.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

24.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell transcriptomic analysis identifies a tumor-enriched GIMAP7⁺ CD4⁺ naïve T cell population with a unique immunoregulatory state in lung adenocarcinoma.

Functional & integrative genomics·2026
Same author

Integrating epidemiological and transcriptomic data reveals novel lipid metabolic drivers of obstructive sleep apnea.

Nutrition & metabolism·2026
Same author

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer.

Cancer cell·2026
Same author

CTSK<sup>+</sup> macrophages drive fibrotic stenosis in benign airway stenosis via the PROS1-AXL pathway.

International immunopharmacology·2026
Same author

Gut microbial metabolites, barrier dysfunction, and endotoxemia in men obstructive sleep apnea-associated hypertension.

iScience·2026
Same author

D-Dimer: A Mediator of the Association Between Lymphocyte and Dissemination of Pulmonary Tuberculosis: A Retrospective Cohort Study.

The clinical respiratory journal·2026

Related Experiment Video

Updated: Aug 26, 2025

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

17.6K

Stem cell-based therapy for pulmonary fibrosis.

Wenzhao Cheng1, Yiming Zeng1, Dachun Wang2,3

  • 1Stem Cell Laboratory, Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

Stem Cell Research & Therapy
|October 4, 2022
PubMed
Summary
This summary is machine-generated.

Stem cell therapy shows promise for treating pulmonary fibrosis (PF), a progressive lung disease. Further research is needed to address safety and efficacy for this condition.

Keywords:
Cell therapyExosomesExtracellular vesiclesPulmonary fibrosisStem cells

More Related Videos

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

3.8K
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:39

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

263

Related Experiment Videos

Last Updated: Aug 26, 2025

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

17.6K
A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

3.8K
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:39

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

263

Area of Science:

  • Regenerative Medicine
  • Pulmonology
  • Cell Biology

Background:

  • Pulmonary fibrosis (PF) is a progressive lung disease characterized by fibroblast and extracellular matrix accumulation, leading to respiratory failure and impaired quality of life.
  • Current treatments for advanced PF are limited, with lung transplantation being the only option, but restricted by surgical complexity and donor availability.
  • There is a critical need for novel therapeutic strategies to address the challenges posed by pulmonary fibrosis.

Purpose of the Study:

  • To review recent preclinical and clinical studies on stem cell-mediated lung regeneration for pulmonary fibrosis.
  • To analyze key issues concerning the safety and therapeutic efficacy of stem cell therapy in treating PF.
  • To guide future therapeutic development for pulmonary fibrosis.

Main Methods:

  • Systematic review of preclinical and clinical research on stem cell therapy for pulmonary fibrosis.
  • Analysis of studies focusing on stem cell-mediated regeneration of fibrotic lung tissue.
  • Evaluation of safety and efficacy data from stem cell transplantation studies in PF models and patients.

Main Results:

  • Stem cells demonstrate potential therapeutic efficacy in preclinical models of lung fibrosis due to their pluripotency and paracrine actions.
  • Literature supports the role of stem cells in regenerating fibrotic lung tissue, offering a promising alternative to current treatments.
  • Key challenges regarding the safety and efficacy of stem cell transplantation for PF require further investigation.

Conclusions:

  • Stem cell therapy represents a promising avenue for treating pulmonary fibrosis, a debilitating lung condition.
  • While preclinical and clinical evidence is encouraging, critical issues of safety and efficacy must be resolved.
  • Continued research and analysis are essential to optimize stem cell-based therapeutic strategies for pulmonary fibrosis.